Recommendation based on a phase 3 study showing a significantly greater proportion of children on Dupixent achieved histological remission, compared to placebo, consistent with improvements seen in ...
Immunosuppressive therapy may help reduce gastrointestinal (GI) symptoms among patients with systemic sclerosis (SSc), according to study results published in RMD Open.